Skip to main content
Home

Main navigation

  • Home
  • Series
  • People
  • Depts & Colleges

Main navigation

  • Home
  • Series
  • People
  • Depts & Colleges

Cancer Informatics

Series
Cancer
Video Audio Embed
Cancer research now generates huge amounts of data, and sophisticated computational tools are needed to answer biological questions. Making sense of this variability at molecular level will help us better tailor treatments to individual cancer patients.
Dr Benjamin Schuster-Böckler heads the computational group at the Ludwig Institute for Cancer Research. His work has demonstrated that epigenetic modifications influence the mutational landscape in cancer cells. He studies the effects of DNA-binding proteins on transcription factors, with the aim to understand the regulation (and mis-regulation) of the transcription of important oncogenes and tumour suppressors.

More in this series

View Series
Cancer

Cancer and innate immunity

Inflammatory signalling
Previous
Cancer

Cancer predisposition and evolution

Identifying genes that increase the risk of bowel or other cancers allows us to offer preventative measures, such as removing tumours at an early stage. A better understanding of how and why cancers grow also helps develop improved treatments.
Next
Licence
Creative Commons Attribution-Non-Commercial-Share Alike 2.0 UK: England & Wales; http://creativecommons.org/licenses/by-nc-sa/2.0/uk/

Episode Information

Series
Cancer
People
Benjamin Schuster-Böckler
Keywords
cancer
data
computational
epigenetic
dna binding proteins
Department: Nuffield Department of Clinical Medicine
Date Added: 09/02/2015
Duration: 00:06:01

Subscribe

Apple Podcast Video Apple Podcast Audio Audio RSS Feed Video RSS Feed

Download

Download Video Download Audio

Footer

  • About
  • Accessibility
  • Contribute
  • Copyright
  • Contact
  • Privacy
'Oxford Podcasts' Twitter Account @oxfordpodcasts | MediaPub Publishing Portal for Oxford Podcast Contributors | Upcoming Talks in Oxford | © 2011-2022 The University of Oxford